A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM)

by | Mar 30, 2026 | Clinical Trials | 0 comments

​ Conditions: Recurrent Glioblastoma Multiforme(GBM)

Interventions: Biological: JL15003Injection

Sponsors: Jecho Biopharmaceuticals Co., Ltd.

Recruiting Conditions: Recurrent Glioblastoma Multiforme(GBM)
Interventions: Biological: JL15003Injection
Sponsors: Jecho Biopharmaceuticals Co., Ltd.
Recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *